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Genetic model
Dear Editor:
We would like to comment on the article ‘KCNQ1 rs2237892 C?T
gene polymorphism and type 2 diabetes mellitus in the Asian popula-
tion: a meta-analysis of 15,736 patients’ by Li Yan-yan et al. on the
definition of genetic models (J Cell Mol Med 2014; 18 (2): 274–82).
Classically, there are three genotypic test models, i.e. dominant/re-
cessive/additive for exploring the genotypic and phenotypic associa-
tion studies. In Li et al.’s article, unfortunately, the authors gave a
wrong description on the dominant and recessive models.
Up to date, there is often no concrete evidence of the genetic
mode of inheritance in the studies of complex disease genes. Most
studies test multiple genetic models to explore the biological rationale
behind the preference of these genetic models. Dominance of one of
the alleles can be assumed by treating the heterozygote and one of
the homozygote genotypes as a single category. For example, if the
alleles of the gene of interest are A and B in haploid, and A is the
‘increasing’ or ‘risk’ allele, i.e. the one causing an effect, the three
genotype groups would then be AA, AB and BB. This dichotomization
of the SNP genotypes can be done as follows:
 Dominant: ‘AA + AB’ versus ‘BB’,
 Recessive: ‘AA’ versus ‘AB + BB’,
 Additive: ‘AA’ versus ‘AB’ versus ‘BB’.
In Li et al.’s study, when dominance of the T allele is assumed,
the dominant genetic model would be ‘TT+CT’ versus ‘CC’, not ‘CC’
versus ‘CT+TT’. This is consistent with the recessive model ‘TT’ ver-
sus ‘CC+CT’ referred in this article. As a result, the carriers of
rs2237892-T (TT+CT) have a decreased risk for T2DM (OR = 0.69;
95% CI: 0.64–0.74) and not an increase risk as reported (OR = 1.45;
95% CI: 1.286–1.634). Thus, if we refer to C, the dominant genetic
model would be ‘CC+CT’ versus ‘TT’, with ‘CC’ versus ‘TT+CT’ as a
recessive model. Accordingly the other relevant calculations in the Li
et al.’s paper should be corrected as well.
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